Synonyms 碳酸酐酶Ⅲ, CA-III, CA3 + [6] |
Introduction Reversible hydration of carbon dioxide. |
Target |
Mechanism CA2 inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date15 Nov 2022 |
Target |
Mechanism CA3 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism CA3 inhibitors |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date01 Mar 2024 |
Sponsor / Collaborator |
Start Date19 Jun 2018 |
Sponsor / Collaborator |
Start Date01 May 2018 |
Sponsor / Collaborator |